Closed jharenza closed 2 years ago
We don’t use the whole GOI list by default and in the publication plots we use the top 20 genes when using a GOI list. Since all embryonal tumors are plotted together, it would not surprise me if the top 20 cutoff is the culprit.
First step should check the underlying files used for the oncoprints, though.
We don’t use the whole GOI list by default and in the publication plots we use the top 20 genes when using a GOI list. Since all embryonal tumors are plotted together, it would not surprise me if the top 20 cutoff is the culprit.
First step should check the underlying files used for the oncoprints, though.
That's true, but I also see genes mutated in only one sample in those plots, and with there being a few ATRTs in the plot, I would have thought we'd capture some SMARCB1, as we do in pedcbio. I think we also need to check whether the samples in pedcbio harboring the mutations exist in the oncoprint and if so, why aren't they showing up here. I think maybe this is the culprit, but want to be sure so we can explain it.
@jharenza, so I looked into this - and the reason is due to the top20 filter for GOI list.
"SMARCB1" %in% filtered_maf_object@data[["Hugo_Symbol"]]
is TRUE)AlteredSamples
>2 and 14 genes with AlteredSamples
=2. APC
, CTDNEP1
and FOXO3
were selected because of this) Let me know if there are anything else that you want me to look into.
Thanks for this! We may want to prioritize the genes being shown in this specific plot - let me think about it.
going to close this since these genes are not technically missing
What analysis module should be updated and why?
oncoprint landscape - the embryonal tumor plot for ATRTs is missing SMARCB1, the major driver mutation
What changes need to be made? Please provide enough detail for another participant to make the update.
Not sure why this is missing - see this pedcbio page - we seem to be missing the variant calls and two homodeletions. It is possible some of the samples in pedcbio do not overlap with the independent specimen list, but we need to investigate this, as missing this key alteration is a red flag. SMARCB1 is in the GOI list here: https://github.com/AlexsLemonade/OpenPBTA-analysis/blob/d31c927a27813ec0b8032fbe768002f31723636f/analyses/oncoprint-landscape/data/embryonal-tumor_goi_list.tsv#L63
What input data should be used? Which data were used in the version being updated?
v21
When do you expect the revised analysis will be completed?
this week?
Who will complete the updated analysis?
@runjin326